Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy
Ding Luo,Xiaoyong Dai,He Tian,Chunlin Fan,Huayan Xie,Nenghua Chen,Jinghao Wang,Laiqiang Huang,Hao Wang,Guocai Wang,Yubo Zhang
DOI: https://doi.org/10.1016/j.phymed.2023.154909
IF: 6.656
2023-05-31
Phytomedicine
Abstract:Abstact Background Novel compounds and more efficient treatment options are urgently needed for the treatment of non-small cell lung cancer (NSCLC). The decoction of Sophora flavescens has been used to treat NSCLC in the clinic, and matrine-type alkaloids are generally considered to be the key pharmacodynamic material basis. But the previous study showed that common matrine-type alkaloids exhibit significant cytotoxicity only when at concentrations close to the millimolar (mM) level. The key antitumor alkaloids in S. flavescens seem to have not yet been revealed. Purpose The aim of this study was to screen water-soluble matrine alkaloid with novel skeleton and enhanced activity from S. flavescens , and to reveal the pharmacological mechanism of its therapeutic effect on NSCLC. Methods Alkaloid was obtained from S. flavescens by chromatographic separation methods. The structure of alkaloid was determined by spectroscopic methods, and single-crystal X-ray diffraction. The mechanism of anti-NSCLC in vitro with cellular models was evaluated by MTT assay, western blotting, cell migration and invasion assay, plate colony-formation assay, tube formation assay, immunohistochemistry assay, hematoxylin and eosin staining. The antitumor efficacy in vivo was test in NSCLC xenograft models. Results A novel water-soluble matrine-derived alkaloid incorporating 6/8/6/6 tetracyclic ring system, named sophflarine A (SFA), was isolated from the roots of S. flavescens . SFA had significantly enhanced cytotoxicity compared with the common matrine-type alkaloids, having an IC 50 value of 11.3 μM in A549 and 11.5 μM in H820 cells at 48h. Mechanistically, SFA promoted NSCLC cell death by inducing pyroptosis via activating the NLRP3/caspase-1/GSDMD signaling pathway, and inhibited cancer cell proliferation by increasing the ROS production to activate autophagy via blocking the PI3K/AKT/mTOR signaling pathway. Additionally, SFA also inhibited NSCLC cell migration and invasion by suppressing EMT pathway, and inhibited cancer cell colony formation and human umbilical vein endothelial cell angiogenesis. In concordance with the above results, SFA treatment blocked tumor growth in an A549 cell-bearing orthotopic mouse model. Conclusion This study revealed a potential therapeutic mechanism of a novel matrine-derived alkaloid, which not only described a rational explanation for the clinical utilization of S. flavescens , but also provided a potential candidate compound for NSCLC treatment.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences